Independent Director · Elicio Therapeutics, Inc. (ELTX)

Allen R. Nissenson, M.D — Elicio Therapeutics Director Compensation (2024)

Fiscal year 2024 director compensation for Allen R. Nissenson, M.D at Elicio Therapeutics, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 9, 2025 (DEF 14A). Open the filing on EDGAR.

Free

Get Allen R. Nissenson, M.D’s full pay file as a PDF — free

More than this page: up to 10 years of Allen’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Allen R. Nissenson, M.D and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Elicio Therapeutics Director Compensation Table · all 3 fiscal years held
In US dollars, as Elicio Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$52,500—$37,758—$90,258
FY2024$48,125$0$17,148$0$65,273
FY2021$62,500$0$138,029—$200,529

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Elicio Therapeutics, Inc. DEF 14A filed April 9, 2025, accession 0001601485-25-000062, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Elicio Therapeutics, Inc. filed document, accession 0001601485-25-000062. Every figure is read from that document and cited to the page and table it appears in. Filed April 9, 2025.

Get the Elicio Therapeutics Board Governance Report

$65,273 Allen R. Nissenson, M.D, FY2024 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 9, 2025 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2024

Elicio Therapeutics pays directors a $40,000 cash retainer and $17,148 in Options.

Committees

FY2024 · as the proxy prints them

Audit · Compensation · Nominating/Governance

The rest of the Elicio Therapeutics board

FY2024 · as the company reported each
DirectorRoleFY2024 total
Carol AsheIndependent Director$79,648
Jay R. Venkatesan, M.DDirector$57,148
Julian Adams, Ph.DChair of the Board$104,523
Karen J. WilsonIndependent Director$77,148
Robert ConnellyDirector—
Robert R. Ruffolo, Jr., Ph.D., FCPPDirector$62,148
Yekaterina (Katie) ChudnovskyDirector$60,717

The full Elicio Therapeutics compensation record

free company brief

This page is one director within Elicio Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the Elicio Therapeutics proxy · each links to its own free brief

Order ELTX

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report